found that serum TTR is not only a nutritional marker but also a significant prognostic factor in palliative settings.7 However, there are currently no studies that have investigated prognostic factors in patients with terminal cancer according to cancer type, such as pancreatic cancer. The gene discussed is TTR; the disease is familial pancreatic carcinoma.